1-6 of 6
Keywords: carbidopa
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Articles
Clin Sci (Lond) (1988) 75 (5): 503–507.
Published: 01 November 1988
... acids l -dopa ( l -3,4-dihydroxyphenylalanine) and 5-hydroxytryptophan. During the final two clearance periods, the peripheral decarboxylase inhibitor, carbidopa ( S -α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid monohydrate), was infused additionally. 2. Renal formation of dopamine (3,4...
Articles
Articles
Clin Sci (Lond) (1981) 61 (2): 187–190.
Published: 01 August 1981
... received in a randomized order placebo, l-dopa (500 mg, orally) and l-dopa (100 mg, orally) plus carbidopa (35 mg, orally) after pretreatment with carbidopa (50 mg every 6 h for four doses). 3. l-Dopa administration elicited a significant fall in plasma renin activity (PRA) ( P < 0.01 at 120, 150...
Articles
Clin Sci Mol Med (1978) 55 (s4): 255s–257s.
Published: 01 December 1978
... in mean arterial pressure) at 20–80 mg/kg intraperitoneally or 80 mg/kg orally. The maximal effect is reached at 4 h after treatment and the duration of action exceeds 12 h. 2. A peripheral inhibitor of amino acid decarboxylase, carbidopa ([—]-l-α-hydrazino-3,4-dihydroxy-α-methylbenzenepropanoic acid...
Articles